JAHA:重复测量血清尿酸与房颤风险

2019-06-21 xing.T MedSci原创

由此可见,高血清尿酸盐水平和血清尿酸盐随时间的增加与AF的风险增加相关。血清尿酸盐和高敏感性C-反应蛋白处于高水平的患者具有显著更高的AF风险。

关于血清尿酸盐与房颤(AF)风险之间关联的当前证据受到了横断面设计和单次血清尿酸测量的限制。血清尿酸盐、痛风相关炎症和全身性炎症在AF病因学中的作用目前尚不清楚。鉴于全身性炎症是AF的公认危险因素,明确它们之间的关系很重要。 

近日,心血管疾病领域权威杂志JAHA上发表了一篇研究文章,研究人员对2006年至2014年的123238名中国患者进行了一项前瞻性队列研究。在2006年、2008年、2010年和2012年测量了受试者血清中尿酸盐浓度。通过两年一次的12导联心电图检查确定了AF事件。研究人员使用Cox比例风险模型来评估累积平均血清尿酸盐的性别特异性关联和血清尿酸盐的变化,并考虑基线水平与事件性AF的风险。研究人员还评估了血清尿酸盐和高敏C-反应蛋白水平的联合关联。

血清尿酸盐最低五分位数的参与者相比,最高五分位数参与者AF风险高出1.91倍(校正风险比:1.91; 95%CI为1.32-2.76;趋势P=0.001)。与血清尿酸盐和高敏C反应蛋白水平正常的患者相比,高血清尿酸盐和高敏C反应蛋白的参与者发生AF的风险增加2.6倍(校正风险比:2.63; 95%CI为1.63-4.23)。

由此可见,高血清尿酸盐水平和血清尿酸盐随时间的增加与AF的风险增加相关。血清尿酸盐和高敏感性C-反应蛋白处于高水平的患者具有显著更高的AF风险。 

原始出处:

Shanshan Li.et al.Cohort Study of Repeated Measurements of Serum Urate and Risk of Incident Atrial Fibrillation.JAHA.2019.https://www.ahajournals.org/doi/10.1161/JAHA.119.012020

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=368843, encodeId=f11e36884311, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Jul 02 19:14:55 CST 2019, time=2019-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268164, encodeId=118412681642c, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Jun 23 09:57:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466369, encodeId=683f14663690f, content=<a href='/topic/show?id=6eda8939206' target=_blank style='color:#2F92EE;'>#血清尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89392, encryptionId=6eda8939206, topicName=血清尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99066802687, createdName=feifers, createdTime=Sun Jun 23 09:57:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532020, encodeId=1f0915320205a, content=<a href='/topic/show?id=b0885428229' target=_blank style='color:#2F92EE;'>#房颤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54282, encryptionId=b0885428229, topicName=房颤风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ea612304943, createdName=whmdzju, createdTime=Sun Jun 23 09:57:00 CST 2019, time=2019-06-23, status=1, ipAttribution=)]
    2019-07-02 一个字-牛

    学习了谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=368843, encodeId=f11e36884311, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Jul 02 19:14:55 CST 2019, time=2019-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268164, encodeId=118412681642c, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Jun 23 09:57:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466369, encodeId=683f14663690f, content=<a href='/topic/show?id=6eda8939206' target=_blank style='color:#2F92EE;'>#血清尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89392, encryptionId=6eda8939206, topicName=血清尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99066802687, createdName=feifers, createdTime=Sun Jun 23 09:57:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532020, encodeId=1f0915320205a, content=<a href='/topic/show?id=b0885428229' target=_blank style='color:#2F92EE;'>#房颤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54282, encryptionId=b0885428229, topicName=房颤风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ea612304943, createdName=whmdzju, createdTime=Sun Jun 23 09:57:00 CST 2019, time=2019-06-23, status=1, ipAttribution=)]
    2019-06-23 zhaohui6731
  3. [GetPortalCommentsPageByObjectIdResponse(id=368843, encodeId=f11e36884311, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Jul 02 19:14:55 CST 2019, time=2019-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268164, encodeId=118412681642c, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Jun 23 09:57:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466369, encodeId=683f14663690f, content=<a href='/topic/show?id=6eda8939206' target=_blank style='color:#2F92EE;'>#血清尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89392, encryptionId=6eda8939206, topicName=血清尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99066802687, createdName=feifers, createdTime=Sun Jun 23 09:57:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532020, encodeId=1f0915320205a, content=<a href='/topic/show?id=b0885428229' target=_blank style='color:#2F92EE;'>#房颤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54282, encryptionId=b0885428229, topicName=房颤风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ea612304943, createdName=whmdzju, createdTime=Sun Jun 23 09:57:00 CST 2019, time=2019-06-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=368843, encodeId=f11e36884311, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160304/IMG56D94856B1B5D6405.jpg, createdBy=27931687771, createdName=一个字-牛, createdTime=Tue Jul 02 19:14:55 CST 2019, time=2019-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268164, encodeId=118412681642c, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sun Jun 23 09:57:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466369, encodeId=683f14663690f, content=<a href='/topic/show?id=6eda8939206' target=_blank style='color:#2F92EE;'>#血清尿酸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89392, encryptionId=6eda8939206, topicName=血清尿酸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99066802687, createdName=feifers, createdTime=Sun Jun 23 09:57:00 CST 2019, time=2019-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532020, encodeId=1f0915320205a, content=<a href='/topic/show?id=b0885428229' target=_blank style='color:#2F92EE;'>#房颤风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54282, encryptionId=b0885428229, topicName=房颤风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ea612304943, createdName=whmdzju, createdTime=Sun Jun 23 09:57:00 CST 2019, time=2019-06-23, status=1, ipAttribution=)]

相关资讯

SPSS进行重复测量的多因素方差分析

1、概述 重复测量数据的方差分析是对同一因变量进行重复测量的一种试验设计技术。在给予一种或多种处理后,分别在不同的时间点上通过重复测量同一个受试对象获得的指标的观察值,或者是通过重复测量同一个个体的不同部位(或组织)获得的指标的观察值。重复测量数据在科学研究中十分常见。 分析前要对重复测量数据之间是否存在相关性进行球形检验。如果该检验结果为P﹥0.05,则说明重复测量数据之间不存在相关性,

长城会 2014:中国原创研究:“中年发福”不是健康富态的标志

解放军总医院流行病学教研室何耀教授团队的一项35年随访研究在改革开放前的1976年纳入1696例35~65岁进行健康体检的西安某企业职工。并于1994年对该人群再次体检,对其中符合要求和数据完整的1494人随访至2011年。研究采用队列研究设计,用18年(1976-1994)观察转型期体重及相关指标的变化,随访和观察其后的17年间(1994-2011)上述变化的健康结局。点事件包括心血管病(C